United States· US:42023-104_a97e057f-6554-4ce2-bc75-3ebc1978e0d0
Aplisol
A medicinal product containing tuberculin purified protein derivative, registered in United States by ENDO USA, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TUBERCULIN PURIFIED PROTEIN DERIVATIVE
- Manufacturer
- ENDO USA, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 4
- ndc1142023-104-01
- ndc1142023-104-05
- ndc1142023104011 VIAL in 1 CARTON (42023-104-01) / 1 mL in 1 VIAL
- ndc1142023104051 VIAL in 1 CARTON (42023-104-05) / 5 mL in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tuberculin purified protein derivative in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTuberculin PPD RT23 AJVaccines 10 TU/0,1 mlAJ Vaccines
- FinlandTuberculin PpdStatens Serum Institut
- United KingdomTuberculin PPD RT 23 SSI 100 tuberculin units/ml solution for injection 1.5ml vialsImported (Denmark)
- CzechiaPPD TUBERCULIN MAMMALIAN
- IrelandTuberculin PPD RT23 AJV 2 T.U./0.1 mL, solution for injectionAJ Vaccines A/S
- PolandTuberculin PPD RT23 AJVAJ Vaccines A/S
- CanadaTUBERSOLSANOFI PASTEUR LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Bulgaria · Ппд Туберкулин Мамалиан
- France · Tubertest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6988a64-f805-467c-b90c-78a3d376642a GET /v1/drugs/c6988a64-f805-467c-b90c-78a3d376642a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRADERMAL",
"source": "ndc",
"strength": "5",
"substance": "TUBERCULIN PURIFIED PROTEIN DERIVATIVE",
"productndc": "42023-104",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "[iU]/.1mL",
"application_number": "BLA103782",
"marketing_category": "BLA"
}See everything about tuberculin purified protein derivative.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.